Astragaloside IV supplementation promotes a neuroprotective effect in experimental models of neurological disorders: a systematic review

Página do item simplificado Estatísticas
dc.contributor.authorCosta, Ianara M.
dc.contributor.authorLima, Francisca O. V.
dc.contributor.authorFernandes, Luciana C. B.
dc.contributor.authorNorrara, Bianca
dc.contributor.authorI. Neta, Francisca
dc.contributor.authorAlves, Rodrigo D.
dc.contributor.authorCavalcanti, José R. L. P.
dc.contributor.authorLucena, Eudes Euler de Souza
dc.contributor.authorCavalcante, Jeferson de Souza
dc.contributor.authorRego, Amalia C. M.
dc.contributor.authorAraújo Filho, Irami
dc.contributor.authorQueiroz, Dinalva B.
dc.contributor.authorFreire, Marco A. M.
dc.contributor.authorGuzen, Fausto P.
dc.date.accessioned2021-03-10T11:26:12Z
dc.date.available2021-03-10T11:26:12Z
dc.date.issued2019-06-19
dc.description.resumoBackground: Neurological disorders constitute a growing worldwide concern due to the progressive aging of the population and the risky behavior they represent. Herbal medicines have scientific relevance in the treatment of these pathologies. One of these substances, Astragaloside IV (AS-IV), is the main active compound present in the root of Astragalus membranaceus (Fisch.) Bge, a Chinese medicinal herb with neuroprotective properties. Objective: In the present study we performed a systematic review that sought to comprehend the neuroprotective effect presented by AS-IV in experimental models of neurological disorders. Methods: This study is a systematic review, where an electronic search in United States National Library of Medicine (PubMed), Science Direct, Cochrane Library, Scientific Electronic Library Online (SciELO), Scopus, Web of Science, Medline via Proquest and Periodicos Capes databases covering the years between 2007 and 2017, using “Astragaloside IV” and “Neurodegenerative diseases”; “Astragaloside IV” and “ Neurological disorders” as reference terms was made. Results: A total of 16 articles were identified, in which the efficacy of AS-IV was described in experimental models of Parkinson’s disease, Alzheimer’s disease, cerebral ischemia and autoimmune encephalomyelitis, by improving motor deficits and/or neurochemical activity, especially antioxidant systems, reducing inflammation and oxidative stress. Conclusion: The findings of the present study indicate that the administration of AS-IV can improve behavioral and neurochemical deficits largely due to its antioxidant, antiapoptotic and antiinflammatory properties, emerging as an alternative therapeutic approach for the treatment of neurological disorderspt_BR
dc.identifier.citationCOSTA, Ianara M. et al. Astragaloside IV supplementation promotes a neuroprotective effect in experimental models of neurological disorders: a systematic review. Current Neuropharmacology, [s. l.], v. 17, n. 7, p. 648-665, 19 jun. 2019. Bentham Science Publishers Ltd. Disponível em: https://www.eurekaselect.com/165301/article. Acesso em: 20 jul. 2020. http://dx.doi.org/10.2174/1570159x16666180911123341.pt_BR
dc.identifier.doi10.2174/1570159x16666180911123341
dc.identifier.issn1570-159X (Print)
dc.identifier.urihttps://repositorio.ufrn.br/handle/123456789/31786
dc.languageenpt_BR
dc.publisherBentham Science Publisherspt_BR
dc.rightsAttribution 3.0 Brazil*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/br/*
dc.subjectNeurological disorderspt_BR
dc.subjectParkinson’s diseasept_BR
dc.subjectAlzheimer’s diseasept_BR
dc.subjectCerebral ischemiapt_BR
dc.subjectAstragaloside IVpt_BR
dc.subjectBrainpt_BR
dc.titleAstragaloside IV supplementation promotes a neuroprotective effect in experimental models of neurological disorders: a systematic reviewpt_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
AstragalosideIVSupplementationNeuroprotective_Lucena_2019.pdf
Tamanho:
3.84 MB
Formato:
Adobe Portable Document Format
Imagem de Miniatura
 Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar

Coleções

EMCM - Artigos publicados em periódicos
CB - DFIS - Artigos publicados em periódicos
CCS - DCIRUR - Artigos publicados em periódicos
Repositório Institucional - UFRN Campus Universitário Lagoa NovaCEP 59078-970 Caixa postal 1524 Natal/RN - BrasilUniversidade Federal do Rio Grande do Norte© Copyright 2025. Todos os direitos reservados.
Contato+55 (84) 3342-2260 - R232Setor de Repositórios Digitaisrepositorio@bczm.ufrn.br
DSpaceIBICT
OasisBR
LAReferencia
Customizado pela CAT - BCZM